Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert Hecker"'
Autor:
Robert Hecker
Publikováno v:
Australian Prescriber. 18:84-86
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e94b991da30c9c284591208726e112b
https://doi.org/10.18773/austprescr.1995.075
https://doi.org/10.18773/austprescr.1995.075
Autor:
Robert Heckert, Margot van der Goot
Publikováno v:
Social Sciences and Humanities Open, Vol 6, Iss 1, Pp 100344- (2022)
Media reputation is an important asset of every organization but might even be more delicate for a multiple identity organization (MIO). MIOs usually have central, distinctive, and enduring characteristics belonging to two antithetical value systems,
Externí odkaz:
https://doaj.org/article/df3c3ffce56e4a0482a2de79b882cb92
Autor:
Robert Hecker
Publikováno v:
Journal of Gastroenterology and Hepatology. 7:235-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::068c9ef879037fdc80acc33461973535
https://doi.org/10.1111/j.1440-1746.1992.tb00968.x
https://doi.org/10.1111/j.1440-1746.1992.tb00968.x
Autor:
James W. Denham, P. Grantley Gill, Glyn G. Jamieson, David Hetzel, Peter Devitt, Russell Fitch, Robert Britten‐Jones, Geoffrey E. Gibson, Richard L. Abbott, Robert Hecker, Randolph S. Williams, Charles L. Olweny
Publikováno v:
Medical Journal of Australia. 148:9-13
A synchronous chemoradiotherapy schedule of modest dosage has been used in 36 patients with oesophageal cancer since July 1984 at the Royal Adelaide Hospital. The schedule, which comprises two five-day continuous infusions of 5-fluorouracil, each of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887d8c16c623b852558c7b3a976fa773
https://doi.org/10.5694/j.1326-5377.1988.tb104471.x
https://doi.org/10.5694/j.1326-5377.1988.tb104471.x
Autor:
Robert Hecker, Peter B. Ward, Geoff Higgins, Graeme P. Young, David L. Gordon, Justin Labrooy, Noel Bayley, Joseph A. Trapani, Malcolm McDonald
Publikováno v:
Gastroenterology. 89(5)
A randomized double-blind study was carried out in patients with unresolving antibiotic-associated colitis due to Clostridium difficile , to compare the effect of bacitracin (80,000 U/day) with vancomycin (500 mg/day) on the resolution of symptoms, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6023eca7817a99e2eca8ac6402576bcb
https://pubmed.ncbi.nlm.nih.gov/4043661
https://pubmed.ncbi.nlm.nih.gov/4043661